DarioHealth
DRIO
45 hedge funds and large institutions have $38.4M invested in DarioHealth in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 17 closing their positions.
211% more call options, than puts
Call options by funds: $1.2M | Put options by funds: $387K
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
0.33% less ownership
Funds ownership: 2.15% → 1.81% (-0.33%)
22% less funds holding
Funds holding: 58 → 45 (-13)
34% less capital invested
Capital invested by funds: $58M → $38.4M (-$19.6M)
76% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 17
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.49M |
| 2 |
AWAM
Appian Way Asset Management
New York
|
+$561K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$378K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$342K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$160K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CHM
Collaborative Holdings Management
New York
|
-$7.5M |
| 2 |
Millennium Management
New York
|
-$1.79M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$659K |
| 4 |
Renaissance Technologies
New York
|
-$591K |
| 5 |
E
Ergoteles
New York
|
-$343K |
DRIO Hedge Fund Activity: Q3 2022 in Review
45 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q3 2022, worth a combined $38.4M — down 34% from $58M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of DRIO and 4 opened new positions — a net loss of 13 holders — while 13 trimmed existing stakes and 14 added.
The largest buyer was Nantahala Capital Management, adding an estimated $2.49M. The largest seller was Collaborative Holdings Management, exiting entirely with an estimated $7.5M sold.
- 45 institutional investors held DarioHealth (DRIO) as of Q3 2022, down from 58 in Q2 2022.
- Funds reported $38.4M of DarioHealth stock for Q3 2022, down 34% quarter-over-quarter.
- 4 funds opened new DarioHealth positions in Q3 2022 and 17 closed out, a net change of -13 holders.
- The largest DarioHealth buyer in Q3 2022 was Nantahala Capital Management, an estimated $2.49M added.
- The largest DarioHealth seller in Q3 2022 was Collaborative Holdings Management, an estimated $7.5M sold.
Based on aggregated 13F filings for Q3 2022.